Endoscopy for upper GI cancer screening in the general population: A cost-utility analysis

Gastrointestinal Endoscopy

Volumn 74, Issue 3, 2011, Pages

  Gupta, Neil ^a,b   Bansal, Ajay ^a,b   Wani, Sachin B ^a,b   Gaddam, Srinivas ^b   Rastogi, Amit ^a,b   Sharma, Prateek ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CANCER PATIENT; CANCER SCREENING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIGESTIVE SYSTEM CANCER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POPULATION; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; STOMACH ADENOCARCINOMA;

EID: 80052261096     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2011.05.001     Document Type: Article

References (125)

1. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; U.S. Cancer Statistics Working Group United States Cancer Statistics: 1999-2006 incidence and mortality Web-based report Atlanta 2010 [cited 2010] www.cdc.gov/uscs Accessed January 5, 2011
2. Altekruse SF, Kosary CL, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute. Bethesda, MD, [cited based on November 2009 SEER data submission, posted to the SEER web site, 2010]; http://seer.cancer.gov/csr/1975-2007/. Accessed November 1, 2009.
3. G.S. Cooper, T.D. Kou, and A. Chak Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends Am J Gastroenterol 104 2009 1356 1362
4. J.H. Rubenstein, A. Sonnenberg, and J. Davis Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans Gastrointest Endosc 68 2008 849 855
5. D.A. Corley, T.R. Levin, and L.A. Habel Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640 (Pubitemid 34173814)
6. L.B. Gerson, P.W. Groeneveld, and G. Triadafilopoulos Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease Clin Gastroenterol Hepatol 2 2004 868 879 (Pubitemid 39335793)
7. J.M. Inadomi, R. Sampliner, and J. Lagergren Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis Ann Intern Med 138 2003 176 186 (Pubitemid 36231623)
8. D. Provenzale, C. Schmitt, and J.B. Wong Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk Am J Gastroenterol 94 1999 2043 2053 (Pubitemid 29374530)
9. K. Bani-Hani, H. Sue-Ling, and D. Johnston Barrett's oesophagus: results from a 13-year surveillance programme Eur J Gastroenterol Hepatol 12 2000 649 654 (Pubitemid 30433541)
10. M. Conio, S. Blanchi, and G. Lapertosa Long-term endoscopic surveillance of patients with Barrett's esophagus Incidence of dysplasia and adenocarcinoma: a prospective study Am J Gastroenterol 98 2003 1931 1939 (Pubitemid 37185786)
11. K.K. Wang, and R.E. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797 (Pubitemid 351406009)
12. K.K. Wang, M. Wongkeesong, and N.S. Buttar American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma Gastroenterology 128 2005 1471 1505 (Pubitemid 40712197)
13. M.A. Eloubeidi, and D. Provenzale Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans J Clin Gastroenterol 33 2001 306 309 (Pubitemid 32880970)
14. Z.R. Edelstein, M.P. Bronner, and S.N. Rosen Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study Am J Gastroenterol 104 2009 834 842
15. H.B. El-Serag, P. Kvapil, and J. Hacken-Bitar Abdominal obesity and the risk of Barrett's esophagus Am J Gastroenterol 100 2005 2151 2156
16. M. Conio, R. Filiberti, and S. Blanchi Risk factors for Barrett's esophagus: a case-control study Int J Cancer 97 2002 225 229 (Pubitemid 34019959)
17. S. Subramanian, G. Bobashev, and R.J. Morris Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance Cancer Epidemiol Biomarkers Prev 18 2009 1971 1978
18. A. Sonnenberg, F. Delco, and J.M. Inadomi Cost-effectiveness of colonoscopy in screening for colorectal cancer Ann Intern Med 133 2000 573 584
19. A.L. Frazier, G.A. Colditz, and C.S. Fuchs Cost-effectiveness of screening for colorectal cancer in the general population JAMA 284 2000 1954 1961
20. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 149 2008 627 637
21. D.B. Petitti Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine 2nd ed. 2000 Oxford University Press New York
22. Red Book 2008: Pharmacy's Fundamental Reference 2008 Thompson Medical Economics Montvale (NJ)
23. J.H. Rubenstein, J.M. Inadomi, and J.V. Brill Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy Clin Gastroenterol Hepatol 5 2007 312 318 (Pubitemid 46401523)
24. J.M. Inadomi, M. Somsouk, and R.D. Madanick A cost-utility analysis of ablative therapy for Barrett's esophagus Gastroenterology 136 2009 2101 2114 e1-6
25. N. Gupta, A. Wang, and P.E. Young Adherence to surveillance interval guidelines in Barrett's esophagus (BE): analysis from a large multicenter cohort study Gastroenterology 138 5 suppl 1 2010 S640
26. J.A. Abrams, R.C. Kapel, and G.M. Lindberg Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States Clin Gastroenterol Hepatol 7 2009 736 742 quiz 10
27. G.W. Falk, T.M. Ours, and J.E. Richter Practice patterns for surveillance of Barrett's esophagus in the United States Gastrointest Endosc 52 2000 197 203 (Pubitemid 30650254)
28. N.J. Shaheen, P. Sharma, and B.F. Overholt Radiofrequency ablation in Barrett's esophagus with dysplasia N Engl J Med 360 2009 2277 2288
29. H.C. Wolfsen, J.E. Crook, and M. Krishna Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus Gastroenterology 135 2008 24 31 (Pubitemid 351899007)
30. W.L. Curvers, R. Singh, and L.M. Song Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system Gut 57 2008 167 172 (Pubitemid 351158041)
31. K.B. Dunbar, P. Okolo 3rd, and E. Montgomery Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: a prospective, randomized, double-blind, controlled, crossover trial Gastrointest Endosc 70 2009 645 654
32. P. Sharma, A. Bansal, and R.H. Hawes Detection of Metaplasia (IM) and neoplasia in patients with Barrett's esophagus (BE) using high-definition white light endoscopy (HD-WLE) versus narrow band imaging (NBI): a prospective, multi-center, randomized, crossover trial [abstract] Gastrointest Endosc 69 2009 AB135
33. P. Sharma, A. Meining, and E. Coron Detection of neoplastic tissue in Barrett's esophagus with in vivo probe-based confocal endomicroscopy (DONT BIOPCE) final results of a prospective international RCT: image guided versus 4 quadrant random biopsies? Gastroenterology 138 5 suppl 1 2010 S-155
34. S.B. Wani, N. Gupta, and A. Wang The prevalence of dysplasia is increasing in patients with newly diagnosed Barrett's esophagus (BE): secular trends from a large, multicenter, cohort study Gastroenterology 138 5 suppl 1 2010 S-169
35. B.F. Overholt, K.K. Wang, and J.S. Burdick Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia Gastrointest Endosc 66 2007 460 468 (Pubitemid 47304412)
36. P. Sharma, S. Wani, and A.P. Weston A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results Gut 55 2006 1233 1239 (Pubitemid 44277352)
37. R.A. Ganz, B.F. Overholt, and V.K. Sharma Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry Gastrointest Endosc 68 2008 35 40 (Pubitemid 351902211)
38. J. Chennat, V.J. Konda, and A.S. Ross Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinomaan American single-center experience Am J Gastroenterol 104 2009 2684 2692
39. S.D. Crockett, Q.K. Lippmann, and E.S. Dellon Health-related quality of life in patients with Barrett's esophagus: a systematic review Clin Gastroenterol Hepatol 7 2009 613 623
40. M. Kulig, A. Leodolter, and M. Vieth Quality of life in relation to symptoms in patients with gastro-oesophageal reflux diseasean analysis based on the ProGERD initiative Aliment Pharmacol Ther 18 2003 767 776 (Pubitemid 37323641)
41. M.A. Eloubeidi, and D. Provenzale Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus Am J Gastroenterol 95 2000 1881 1887
42. L.B. Gerson, N. Ullah, and T. Hastie Patient-derived health state utilities for gastroesophageal reflux disease Am J Gastroenterol 100 2005 524 533 (Pubitemid 40487547)
43. N.J. Shaheen, B. Green, and R.K. Medapalli The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program Gastroenterology 129 2005 429 436 (Pubitemid 41096631)
44. M.E. Kruijshaar, P.D. Siersema, and A.C. Janssens Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low Gastrointest Endosc 65 2007 26 30 (Pubitemid 44917968)
45. L.S. Xiong, Y. Cui, and J.P. Wang Prevalence and risk factors of Barrett's esophagus in patients undergoing endoscopy for upper gastrointestinal symptoms J Dig Dis 11 2010 83 87
46. W.K. Hirota, T.M. Loughney, and D.J. Lazas Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data Gastroenterology 116 1999 277 285 (Pubitemid 29055349)
47. C. Winters Jr. , T.J. Spurling, and S.J. Chobanian Barrett's esophagus a prevalent, occult complication of gastroesophageal reflux disease Gastroenterology 92 1987 118 124 (Pubitemid 17207669)
48. C.P. Caygill, P.I. Reed, and M.J. Hill An initial comparison of nine centres registering patients with the UK National Barrett's Oesophagus Registry (UKBOR) Eur J Cancer Prev 8 1999 539 542 (Pubitemid 30019694)
49. M.J. Connor, A.P. Weston, and M.S. Mayo The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population Dig Dis Sci 49 2004 920 924 (Pubitemid 39012273)
50. A. Csendes, G. Smok, and P. Burdiles Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux Dis Esophagus 13 2000 5 11
51. G. Prasad, K. Wang, and Y. Romero Secular trends in the epidemiology and natural history of Barrett's esophagus in Olmsted County, MN: a population based cohort study Am J Gastroenterol 104 S3 2009 S13 S14
52. R.M. Zagari, L. Fuccio, and M.A. Wallander Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study Gut 57 2008 1354 1359
53. D.K. Rex, O.W. Cummings, and M. Shaw Screening for Barrett's esophagus in colonoscopy patients with and without heartburn Gastroenterology 125 2003 1670 1677 (Pubitemid 37500431)
54. L.B. Gerson, and S. Banerjee Screening for Barrett's esophagus in asymptomatic women Gastrointest Endosc 70 2009 867 873
55. E.M. Ward, H.C. Wolfsen, and S.R. Achem Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms Am J Gastroenterol 101 2006 12 17 (Pubitemid 43381703)
56. P. Sharma, T.G. Morales, and A. Bhattacharyya Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up Am J Gastroenterol 92 1997 2012 2016 (Pubitemid 27476240)
57. P. Sharma, G.W. Falk, A.P. Weston, D. Reker, M. Johnston, and R.E. Sampliner Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus Clin Gastroenterol Hepatol 4 2006 566 572 (Pubitemid 44308164)
58. W. Hameeteman, G.N. Tytgat, H.J. Houthoff, and J.G. van den Tweel Barrett's esophagus: development of dysplasia and adenocarcinoma Gastroenterology 96 5 Pt 1 1989 1249 1256 (Pubitemid 19126659)
59. J.B. O'Connor, G.W. Falk, and J.E. Richter The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry Am J Gastroenterol 94 1999 2037 2042 (Pubitemid 29374529)
60. T.G. Schnell, S.J. Sontag, and G. Chejfec Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607 1619 (Pubitemid 32523480)
61. A.P. Weston, A.S. Badr, and R.S. Hassanein Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma Am J Gastroenterol 94 1999 3413 3419
62. E.J. Kuipers, A.M. Uyterlinde, and A.S. Pena Long-term sequelae of Helicobacter pylori gastritis Lancet 345 1995 1525 1528
63. F. Petersson, K. Borch, and L.E. Franzen Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis Scand J Gastroenterol 37 2002 262 266 (Pubitemid 34201776)
64. C. Zhang, N. Yamada, and Y.L. Wu Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer World J Gastroenterol 11 2005 791 796 (Pubitemid 40298076)
65. A.C. de Vries, and E.J. Kuipers Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies Helicobacter 12 suppl 2 2007 22 31 (Pubitemid 350076223)
66. N. Amamra, S. Touzet, and C. Colin Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus J Eval Clin Pract 13 2007 789 794 (Pubitemid 47373607)
67. J.M. Streitz Jr. , C.W. Andrews Jr. , and F.H. Ellis Jr. Endoscopic surveillance of Barrett's esophagus Does it help? J Thorac Cardiovasc Surg 105 1993 383 387 discussion 7-8
68. J.H. Peters, G.W. Clark, and A.P. Ireland Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients J Thorac Cardiovasc Surg 108 1994 813 821 discussion 21-2
69. R. Incarbone, L. Bonavina, and G. Saino Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus Surg Endosc 16 2002 263 266 (Pubitemid 34112973)
70. D.M. Aldulaimi, M. Cox, and C.U. Nwokolo Barrett's surveillance is worthwhile and detects curable cancers: a prospective cohort study addressing cancer incidence, treatment outcome and survival Eur J Gastroenterol Hepatol 17 2005 943 950 (Pubitemid 41192133)
71. N.T. Nguyen, P. Schauer, and J.D. Luketich Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia Surgery 127 2000 284 290 (Pubitemid 30140625)
72. J.W. van Sandick, J.J. van Lanschot, and B.W. Kuiken Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma Gut 43 1998 216 222 (Pubitemid 28348324)
73. M.B. Menke-Pluymers, N.W. Schoute, and A.H. Mulder Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus Gut 33 1992 1454 1458
74. W.G. Wolfe, A.L. Vaughn, and H.F. Seigler Survival of patients with carcinoma of the esophagus treated with combined-modality therapy J Thorac Cardiovasc Surg 105 1993 749 755 discussion 55-6
75. S. Natsugoe, M. Baba, and M. Shimada Positive impact on surgical treatment for asymptomatic patients with esophageal carcinoma Hepatogastroenterology 46 1999 2854 2858 (Pubitemid 29525292)
76. J. Dubuc, J.L. Legoux, and M. Winnock Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers Endoscopy 38 2006 690 695 (Pubitemid 44044395)
77. G.Q. Wang, G.G. Jiao, and F.B. Chang Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening Ann Thorac Surg 77 2004 1740 1744
78. O. Hosokawa, T. Miyanaga, and Y. Kaizaki Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry Scand J Gastroenterol 43 2008 1112 1115
79. K. Hanazaki, H. Sodeyama, and M. Wakabayashi Surgical treatment of gastric cancer detected by mass screening Hepatogastroenterology 44 1997 1126 1132 (Pubitemid 27326170)
80. C. Kunisaki, J. Ishino, and S. Nakajima Outcomes of mass screening for gastric carcinoma Ann Surg Oncol 13 2006 221 228 (Pubitemid 43157417)
81. H. Kubota, T. Kotoh, and R. Masunaga Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution Surgery 128 2000 41 47 (Pubitemid 30456894)
82. A. Matsukuma, M. Furusawa, and H. Tomoda A clinicopathological study of asymptomatic gastric cancer Br J Cancer 74 1996 1647 1650 (Pubitemid 26386096)
83. F.H. Ellis Jr. , S.P. Gibb, and E. Watkins Jr. Esophagogastrectomy: a safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia Ann Surg 198 1983 531 540 (Pubitemid 13006881)
84. F.H. Ellis Jr. , G.J. Heatley, and M.J. Krasna Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria J Thorac Cardiovasc Surg 113 1997 836 846 discussion 46-8
85. S. Galandiuk, R.E. Hermann, and D.M. Cosgrove Cancer of the esophagus: the Cleveland Clinic experience Ann Surg 203 1986 101 108 (Pubitemid 16183298)
86. T.R. DeMeester, G. Zaninotto, and K.E. Johansson Selective therapeutic approach to cancer of the lower esophagus and cardia J Thorac Cardiovasc Surg 95 1988 42 54 (Pubitemid 18030608)
87. Y.K. Wu, and K.C. Huang Chinese experience in the surgical treatment of carcinoma of the esophagus Ann Surg 190 1979 361 365
88. D.B. Skinner En bloc resection for neoplasms of the esophagus and cardia J Thorac Cardiovasc Surg 85 1983 59 71 (Pubitemid 13094461)
89. C. Lepage, M. Sant, and A. Verdecchia Operative mortality after gastric cancer resection and long-term survival differences across Europe Br J Surg 97 2010 235 239
90. K.M. Reavis, M.W. Hinojosa, and B.R. Smith Hospital volume is not a predictor of outcomes after gastrectomy for neoplasm Am Surg 75 2009 932 936
91. G.F. Cenitagoya, C.K. Bergh, and J. Klinger-Roitman A prospective study of gastric cancer "real" 5-year survival rates and mortality rates in a country with high incidence Dig Surg 15 1998 317 322 (Pubitemid 28395658)
92. S. Msika, A.M. Benhamiche, and M.A. Tazi Improvement of operative mortality after curative resection for gastric cancer: population-based study World J Surg 24 2000 1137 1142
93. M. Heron, D. Hoyert, and S. Murphy Deaths: final data for 2006 2009 National Center for Health Statistics Hyattsville, MD
94. S.E. Silvis, O. Nebel, and G. Rogers Endoscopic complications: results of the 1974 American Society for Gastrointestinal Endoscopy Survey JAMA 235 1976 928 930
95. A. Habr-Gama, and J.D. Waye Complications and hazards of gastrointestinal endoscopy World J Surg 13 1989 193 201 (Pubitemid 19099240)
96. M.F. Chan Complications of upper gastrointestinal endoscopy Gastrointest Endosc Clin N Am 6 1996 287 303 (Pubitemid 26116043)
97. S.M. Kavic, and M.D. Basson Complications of endoscopy Am J Surg 181 2001 319 332 (Pubitemid 32595678)
98. J.B. Arrowsmith, B.B. Gerstman, and D.E. Fleischer Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy Gastrointest Endosc 37 1991 421 427
99. R. Hart, and M. Classen Complications of diagnostic gastrointestinal endoscopy Endoscopy 22 1990 229 233 (Pubitemid 20334034)
100. L.V. Hernandez, J.W. Jacobson, and M.S. Harris Comparison among the perforation rates of Maloney, balloon, and savary dilation of esophageal strictures Gastrointest Endosc 51 4 pt 1 2000 460 462 (Pubitemid 30204767)
101. M.D. Iannettoni, A.A. Vlessis, and R.I. Whyte Functional outcome after surgical treatment of esophageal perforation Ann Thorac Surg 64 1997 1606 1609 discussion 9-10
102. H.E. Adamek, R. Jakobs, and D. Dorlars Management of esophageal perforations after therapeutic upper gastrointestinal endoscopy Scand J Gastroenterol 32 1997 411 414 (Pubitemid 27223543)
103. C. Ballesta-Lopez, J. Vallet-Fernandez, and M. Catarci Iatrogenic perforations of the esophagus Int Surg 78 1993 28 31 (Pubitemid 23119599)
104. K. Moghissi, and D. Pender Instrumental perforations of the oesophagus and their management Thorax 43 1988 642 646
105. D. Provenzale, J.A. Kemp, and S. Arora A guide for surveillance of patients with Barrett's esophagus Am J Gastroenterol 89 1994 670 680 (Pubitemid 24132045)
106. S.C. Raftopoulos, D.S. Segarajasingam, and V. Burke A cohort study of missed and new cancers after esophagogastroduodenoscopy Am J Gastroenterol 105 2010 1292 1297
107. D. Katz, R. Rothstein, and A. Schned The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus Am J Gastroenterol 93 1998 536 541 (Pubitemid 29080999)
108. S.B. Wani, G.W. Falk, and M. Hall Low risk of developing dysplasia and esophageal adenocarcinoma (EAC) in patients with non-dysplastic Barrett's esophagus (BE): results from a large, multicenter, cohort study Gastroenterology 138 5 suppl 1 2010 S-63
109. M. Sikkema, P.J. de Jonge, and E.W. Steyerberg Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis Clin Gastroenterol Hepatol 8 2010 235 244 quiz e32
110. A. Rastogi, S. Puli, and H.B. El-Serag Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis Gastrointest Endosc 67 2008 394 398 (Pubitemid 351260043)
111. A.P. Weston, P. Sharma, and M. Topalovski Long-term follow-up of Barrett's high-grade dysplasia Am J Gastroenterol 95 2000 1888 1893
112. C.S. Robertson, J.F. Mayberry, and D.A. Nicholson Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus Br J Surg 75 1988 760 763
113. A.C. de Vries, N.C. van Grieken, and C.W. Looman Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands Gastroenterology 134 2008 945 952 (Pubitemid 351451990)
114. A.P. Weston, A.S. Badr, and R.S. Hassanein Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus Am J Gastroenterol 94 1999 3420 3426
115. C. Hur, E. Wittenberg, and N.S. Nishioka Quality of life in patients with various Barrett's esophagus associated health states Health Qual Life Outcomes 4 2006 45
116. P.F. Stalmeier, A.G. de Boer, and M.A. Sprangers Validity of utilities of patients with esophageal cancer Int J Technol Assess Health Care 21 2005 113 118 (Pubitemid 40229376)
117. A.G. de Boer, P.F. Stalmeier, and M.A. Sprangers Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences Br J Cancer 86 2002 851 857 (Pubitemid 34271018)
118. C.H. Ahern, and Y. Shen Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cancer Epidemiol Biomarkers Prev 18 2009 718 725
119. K.L. Andersson, J.A. Salomon, and S.J. Goldie Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis Clin Gastroenterol Hepatol 6 2008 1418 1424
120. J.H. Rubenstein, A.K. Waljee, and J.M. Jeter Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates Am J Gastroenterol 104 2009 2222 2232
121. J.J. Kim, and S.J. Goldie Health and economic implications of HPV vaccination in the United States N Engl J Med 359 2008 821 832
122. S.F. Altekruse, C. K, M. Krapcho, and N. Neyman SEER Cancer Statistics Review, 1975-2007 Bethesda, MD: National Cancer Institute; [cited based on November 2009 SEER data submission, posted to the SEER web site, 2010] http://seer.cancer.gov/csr/1975-2007/
123. J.M. Inadomi, M. Somsouk, and R.D. Madanick A cost-utility analysis of ablative therapy for Barrett's esophagus Gastroenterology 136 2009 2101 2114 e1-6
124. K.K. Wang, and R.E. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 3 2008 788 797 (Pubitemid 351406009)
125. K.K. Wang, M. Wongkeesong, and N.S. Buttar American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma Gastroenterology 128 5 2005 1471 1505 (Pubitemid 40712197)